MedPath

The intradialytic clearance of polyclonal immunoglobulin free light chains by low-flux hemodialysis, high-flux hemodialysis and online hemodiafiltration .

Conditions
End stage renal disease
infections
10027665
10004018
10038430
Registration Number
NL-OMON35927
Lead Sponsor
Maasstadziekenhuis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
15
Inclusion Criteria

Prevalent hemodialysis patients, treated with hemodialysis 3 times a week (for at least 2 months) with a minimum dialysis urea Kt/V >= 1.2 and who are able to understand the study procedures.

Exclusion Criteria

Exclusion criteria are age < 18 years, treatment by hemodiafiltration or high-flux hemodialysis in the 6 months preceding entering this study, severe incompliance defined as non-adherence to the dialysis prescription and a life expectancy < 3 months due to causes other than kidney disease. Hemoglobin level < 6.0 mmol/L.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The difference in change of immunoglobulin free light chain serum concentration<br /><br>during the hemodialysis session. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>N.a.</p><br>
© Copyright 2025. All Rights Reserved by MedPath